Oral Abstract Session: Encapsulation of cellular transplants 1
Saturday October 28, 2023 from 14:00 to 15:30
Indigo D
Moderators
Lectures
-
328.1 Preliminary results on the survival and maturation of stem-cell derived beta cells at different stages in a novel immunoprotective double encapsulation deviceMr. Praveen Kumar Raju Pedabaliyarasimhuni, Canada
-
328.2 A bioengineered artificial interstitium supports long-term survival of therapeutic xenogeneic porcine islet cells in nonhuman primates without immunosuppressionDr. David J Leishman, United States
-
328.3 An oxygen-delivering Hyaluronic acid-based matrix reduces inflammation and promotes human islet survival in macroencapsulation devicesPaul R.V. Johnson, United Kingdom
-
328.4 How to deliver a therapeutic dose of encapsulated human islets?Dr. Rosy Eloy, France
-
328.5 Islet encapsulation preserves their functionality following transplantation into immunocompetent diabetic animals without immunosuppression.Dr. Harald Stover, Canada
-
328.6 Alginate-based (G) microcapsules (MC): a versatile tool for the experimental cell therapy and prevention of T1DProf. Riccardo Calafiore, Italy
-
328.7 Survival and function of the adrenal cell in immunoisolation device in adrenalectomized mice and sheep.Mrs. Lina Mariana, Australia
-
328.8 A novel endovascular bioartificial pancreas device to treat type 1 diabetesDr. Sara Photiadis, United States
-
328.9 Development, optimization, and preclinical evaluation of a bio-artificial pancreas for the treatment of type 1 diabetes (T1D)Mrs. Sawsen Bekir, France